1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 17
2 Introduction 18
2.1 Drug Eluting Stents (DES) Overview 18
3 Products under Development 19
3.1 Drug Eluting Stents (DES) – Pipeline Products by Stage of Development 19
3.2 Drug Eluting Stents (DES) – Pipeline Products by Territory 20
3.3 Drug Eluting Stents (DES) – Pipeline Products by Regulatory Path 21
3.4 Drug Eluting Stents (DES) – Pipeline Products by Estimated Approval Date 22
3.5 Drug Eluting Stents (DES) – Ongoing Clinical Trials 23
4 Drug Eluting Stents (DES) – Pipeline Products under Development by Companies 24
4.1 Drug Eluting Stents (DES) Companies – Pipeline Products by Stage of Development 24
4.2 Drug Eluting Stents (DES) – Pipeline Products by Stage of Development 27
5 Drug Eluting Stents (DES) Companies and Product Overview 30
5.1 Aachen Resonance GmbH Company Overview 30
5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
5.2 Abbott Vascular Inc. Company Overview 31
5.2.1 Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.3 Adcomp Technologies Inc. Company Overview 35
5.3.1 Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.4 Aeon Bioscience Company Overview 36
5.4.1 Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 AlviMedica Medical Technologies Inc. Company Overview 37
5.5.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Amaranth Medical Inc Company Overview 44
5.6.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.7 Arravasc Ltd Company Overview 46
5.7.1 Arravasc Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
5.8 B. Braun Melsungen AG Company Overview 47
5.8.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview 47
5.9 Biosensors International Group Ltd Company Overview 48
5.9.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Biotronik SE & Co KG Company Overview 56
5.10.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 Boston Scientific Corp Company Overview 72
5.11.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 72
5.12 Cardionovum GmbH Company Overview 76
5.12.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
5.13 CARDIOREV PTE. LTD Company Overview 77
5.13.1 CARDIOREV PTE. LTD Pipeline Products & Ongoing Clinical Trials Overview 77
5.14 Columbia University Company Overview 78
5.14.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 78
5.15 Contego Medical, LLC Company Overview 79
5.15.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 79
5.16 Cordis Corp Company Overview 80
5.16.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 80
5.17 DISA Vascular (Pty) Ltd. Company Overview 85
5.17.1 DISA Vascular (Pty) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 85
5.18 Divya Laboratories Company Overview 86
5.18.1 Divya Laboratories Pipeline Products & Ongoing Clinical Trials Overview 86
5.19 Elixir Medical Corp Company Overview 87
5.19.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 87
5.20 Envision Scientific Pvt. Ltd Company Overview 90
5.20.1 Envision Scientific Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 90
5.21 I.B.S. S.p.A. Company Overview 92
5.21.1 I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 92
5.22 InspireMD Inc Company Overview 93
5.22.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 93
5.23 Kaneka Corp Company Overview 95
5.23.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 95
5.24 Lepu Medical Technology (Beijing) Co Ltd Company Overview 97
5.24.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 97
5.25 Medinol Ltd Company Overview 102
5.25.1 Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview 102
5.26 Medlogics Device Corp Company Overview 108
5.26.1 Medlogics Device Corp Pipeline Products & Ongoing Clinical Trials Overview 108
5.27 Medtronic plc Company Overview 109
5.27.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 109
5.28 Meril Life Sciences Pvt Ltd Company Overview 117
5.28.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 117
5.29 Micell Technologies Inc Company Overview 123
5.29.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 123
5.30 MicroPort Scientific Corp Company Overview 127
5.30.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 127
5.31 Minvasys Company Overview 131
5.31.1 Minvasys Pipeline Products & Ongoing Clinical Trials Overview 131
5.32 MIV Therapeutics Inc Company Overview 132
5.32.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 132
5.33 Northwestern University Company Overview 136
5.33.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 136
5.34 NuVascular Technologies Inc Company Overview 138
5.34.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 138
5.35 OrbusNeich Company Overview 139
5.35.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 139
5.36 Relisys Medical Devices Ltd Company Overview 146
5.36.1 Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 146
5.37 REVA Medical Inc Company Overview 148
5.37.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 148
5.38 Rontis AG Company Overview 150
5.38.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 150
5.39 Sino Medical-Device Technology Co., Ltd. Company Overview 151
5.39.1 Sino Medical-Device Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 151
5.40 Stentys SA Company Overview 155
5.40.1 Stentys SA Pipeline Products & Ongoing Clinical Trials Overview 155
5.41 Svelte Medical Systems, Inc. Company Overview 157
5.41.1 Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.42 Terumo Corp Company Overview 161
5.42.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 161
5.43 Tryton Medical Inc Company Overview 163
5.43.1 Tryton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 163
5.44 University of Alabama at Birmingham Company Overview 166
5.44.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview 166
5.45 University of Florida Company Overview 168
5.45.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 168
5.46 University of Strathclyde Company Overview 170
5.46.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 170
5.47 Vascular Concepts Ltd Company Overview 172
5.47.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 172
5.48 Zorion Medical Company Overview 175
5.48.1 Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview 175
6 Drug Eluting Stents (DES)- Recent Developments 177
6.1 Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 177
6.2 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 178
6.3 Nov 21, 2016: OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing 180
6.4 Nov 18, 2016: MicroPort’s Firesorb Stars in TCT 2016 181
6.5 Nov 18, 2016: MicroPort’s Firehawk Stars in TCT 2016 182
6.6 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 182
6.7 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 183
6.8 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 183
6.9 Nov 07, 2016: Medinol receives approval from the Japanese PMDA to begin clinical study on novel DES 185
6.10 Nov 07, 2016: ARIAD Reports Third Quarter 2016 Financial Results 186
6.11 Nov 01, 2016: TCT 2016: Physicians Share Positive Experiences with Magmaris Resorbable Scaffold at Symposium 188
6.12 Oct 31, 2016: First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes 189
6.13 Oct 31, 2016: TCT 2016: Orsiro Drug-Eluting Stent Proves Non-Inferiority to Resolute Integrity and Synergy Stents 190
6.14 Oct 31, 2016: Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 191
6.15 Oct 31, 2016: Svelte Medical Systems Announces Start of DIRECT III Post-Market Registry Study 192
6.16 Oct 30, 2016: Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity DES 192
6.17 Oct 28, 2016: Tryton Medical Enters Into Strategic Agreement with Cardinal Health 193
6.18 Oct 28, 2016: MicroPort Wins Annual PMO Award of PMI (China) 194
6.19 Oct 28, 2016: REVA Medical: Quarter Ended 30 September 2016 195
6.20 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 195
6.21 Oct 24, 2016: Svelte Medical Systems Announces CE Mark Certification of DIRECT RX 197
6.22 Oct 19, 2016: Firehawk Receives South Korea KGMP Certification 198
6.23 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 198
6.24 Oct 19, 2016: Elixir Medical Announces Schedule of Programs for TCT 2016 200
6.25 Oct 17, 2016: Tryton Medical Announces Clinical Symposium on Treatment of Complex Bifurcation Lesions at TCT 2016 202
6.26 Oct 17, 2016: First Firehawk Implantation in Pakistan Completed 203
6.27 Oct 17, 2016: MicroPort Concludes Enrollment In Randomized, Multicenter, European Study Of Firehawk Coronary Stent System 203
6.28 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 204
6.29 Sep 29, 2016: BIOTRONIK Begins Manufacturing High-Tech Products in Singapore 205
6.30 Sep 15, 2016: STENTYS Reports 2016 First-Half Results 205
6.31 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 207
6.32 Sep 12, 2016: Firehawk Receives Regulatory Approval in Pakistan 207
6.33 Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 208
6.34 Sep 01, 2016: First Firehawk Implantation in East Europe Completed 208
6.35 Aug 30, 2016: BASKET-SAVAGE trial: Drug-eluting stents more benefit in saphenous vein grafts 209
6.36 Aug 30, 2016: MPSC Announces 2016 Interim Results 209
6.37 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 211
6.38 Aug 24, 2016: Firehawk Granted Market Launch in Vietnam 213
6.39 Aug 24, 2016: Innovation, Translation, and Cooperation: MicroPort Attends CHC 2016 to Present Firehawk 214
6.40 Aug 15, 2016: Firehawk Approved for Market Launch in Argentina 215
6.41 Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 215
6.42 Jul 29, 2016: REVA Medical: Quarter Ended 30 June 2016 217
6.43 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 218
6.44 Jul 28, 2016: ARIAD Reports Second Quarter and First Half 2016 Financial Results 219
6.45 Jul 21, 2016: Firehawk Granted Market Approval in India 221
6.46 Jul 21, 2016: Svelte Medical Systems Raises USD4 Million in Venture Financing 222
6.47 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 222
6.48 Jul 19, 2016: STENTYS Enrolls First Patient in Left Main Clinical Trial 224
6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 225
6.50 Jul 12, 2016: STENTYS: 41% Increase in Revenues in the Second Quarter of 2016 225
6.51 Jul 05, 2016: Outcomes from Tryton Medical Pivotal Confirmatory Study Published in JACC Cardiovascular Interventions 225
6.52 Jul 04, 2016: STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO 226
6.53 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 227
6.54 Jun 29, 2016: InspireMD Raises USD14.6 Million in Public Offering of Preferred Stock and Warrants 227
6.55 Jun 20, 2016: Micell Technologies Raises USD25.8 Million in Venture Financing 227
6.56 Jun 17, 2016: ARIAD Completes Strategic Review and Announces Plans for Growth 227
6.57 Jun 15, 2016: BIOTRONIK Announces CE Mark for Magmaris, the First Clinically Proven Bioresorbable Magnesium Scaffold 228
6.58 Jun 08, 2016: STENTYS Announces CE Marking Of Its Longest Xposition Stent 229
6.59 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 229
6.60 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 230
6.61 Jun 03, 2016: Lepu Medical Releases Updates of Clinical trial results of NeoVas Stent in EuroPCR 2016 230
6.62 Jun 03, 2016: LEPUCARE established in India 231
7 Appendix 265
7.1 Methodology 265
7.2 About GlobalData 268
7.3 Contact Us 268
7.4 Disclaimer 268